{{Rsnum
|rsid=8679
|Gene=PARP1
|Chromosome=1
|position=226360853
|Orientation=minus
|GMAF=0.1331
|Gene_s=PARP1
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 5.3 | 32.7 | 61.9
| HCB | 0.0 | 8.8 | 91.2
| JPT | 0.0 | 15.9 | 84.1
| YRI | 0.0 | 4.8 | 95.2
| ASW | 1.8 | 12.3 | 86.0
| CHB | 0.0 | 8.8 | 91.2
| CHD | 0.0 | 11.9 | 88.1
| GIH | 4.0 | 43.6 | 52.5
| LWK | 0.0 | 0.9 | 99.1
| MEX | 1.7 | 27.6 | 70.7
| MKK | 0.0 | 8.3 | 91.7
| TSI | 11.8 | 41.2 | 47.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=22166496
|Title=The role of microRNA-binding site polymorphisms in DNA repair genes as risk factors for bladder cancer and breast cancer and their impact on radiotherapy outcomes
|OA=1
}}

{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}